111 related articles for article (PubMed ID: 21839821)
21. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
[TBL] [Abstract][Full Text] [Related]
22. In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor.
Groo AC; Bossiere M; Trichard L; Legras P; Benoit JP; Lagarce F
Nanomedicine (Lond); 2015 Mar; 10(4):589-601. PubMed ID: 25723092
[TBL] [Abstract][Full Text] [Related]
23. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
24. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
25. Novel long-circulating lipid nanocapsules.
Hoarau D; Delmas P; David S; Roux E; Leroux JC
Pharm Res; 2004 Oct; 21(10):1783-9. PubMed ID: 15553223
[TBL] [Abstract][Full Text] [Related]
26. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
28. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
Abdelwahed W; Degobert G; Fessi H
Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
[TBL] [Abstract][Full Text] [Related]
30. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
[TBL] [Abstract][Full Text] [Related]
31. A synthetic method for peptide-PEG-lipid conjugates: application of octreotide-PEG-DSPE synthesis.
Su JC; Tseng CL; Chang TG; Yu WJ; Wu SK
Bioorg Med Chem Lett; 2008 Aug; 18(16):4593-6. PubMed ID: 18656351
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of decyl-terminated silicon nanoparticles encapsulated in lipid nanocapsules.
Pan GH; Barras A; Boussekey L; Qu X; Addad A; Boukherroub R
Langmuir; 2013 Oct; 29(41):12688-96. PubMed ID: 24083658
[TBL] [Abstract][Full Text] [Related]
33. PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy.
Pereira MA; Mosqueira VC; Vilela JM; Andrade MS; Ramaldes GA; Cardoso VN
Eur J Pharm Sci; 2008 Jan; 33(1):42-51. PubMed ID: 17983736
[TBL] [Abstract][Full Text] [Related]
34. The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
Díaz-López R; Tsapis N; Santin M; Bridal SL; Nicolas V; Jaillard D; Libong D; Chaminade P; Marsaud V; Vauthier C; Fattal E
Biomaterials; 2010 Mar; 31(7):1723-31. PubMed ID: 19948357
[TBL] [Abstract][Full Text] [Related]
35. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments.
Béduneau A; Saulnier P; Hindré F; Clavreul A; Leroux JC; Benoit JP
Biomaterials; 2007 Nov; 28(33):4978-90. PubMed ID: 17716725
[TBL] [Abstract][Full Text] [Related]
36. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
37. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.
Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI
Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
39. Poly(ethylene glycol)-conjugated phospholipids in aqueous micellar solutions: hydration, static structure, and interparticle interactions.
Sato T; Sakai H; Sou K; Buchner R; Tsuchida E
J Phys Chem B; 2007 Feb; 111(6):1393-401. PubMed ID: 17286354
[TBL] [Abstract][Full Text] [Related]
40. Lipid nanocapsules as in vivo oxygen sensors using magnetic resonance imaging.
Nel J; Franconi F; Joudiou N; Saulnier P; Gallez B; Lemaire L
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():396-403. PubMed ID: 31029333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
